首页 News 正文

Two American biotech companies have successfully teamed up with Novo Nordisk, and one of them has nearly doubled its stock price

白云追月素
291 0 0

On Thursday (January 4th) local time, Danish pharmaceutical giant Novo Nordisk announced on its official website that it has reached research cooperation agreements with two American biotech companies, Omega Therapeutics, Inc. and Cellarity Inc., respectively. Specifically, Novo Nordisk will utilize Omega's proprietary platform technology to develop "epigenome controller" drugs that can adjust gene expression without altering the natural nucleic acid sequence of the human body. Novo Nordisk hopes to develop drugs that can enhance cellular metabolic activity as a new method for treating obesity.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

白云追月素 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    39